Sign inGet started

TOTH A ERNEST JR

Insider CIK 1280273 · AQST SVP, Chief Financial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
AQST Aquestive Therapeutics, In F Tax w/h2026-05-052026-05-0792,652$4.18 $387.3K283,460SEC↗
AQST Aquestive Therapeutics, In S Sale2026-03-102026-03-1158,254$4.17 $242.9K376,112SEC↗
AQST Aquestive Therapeutics, In A Award deriv2026-03-092026-03-1170,000— $070,000SEC↗
AQST Aquestive Therapeutics, In A Award2026-03-092026-03-1195,000— $0434,366SEC↗
AQST Aquestive Therapeutics, In F Tax w/h2025-03-092025-03-118,736$2.65 $23.2K339,366SEC↗
AQST Aquestive Therapeutics, In A Award deriv2025-03-072026-04-1382,500— $082,500SEC↗
AQST Aquestive Therapeutics, In A Award deriv2025-03-072025-03-1160,000— $060,000SEC↗
AQST Aquestive Therapeutics, In F Tax w/h2025-03-072025-03-1110,193$2.65 $27.0K348,102SEC↗
AQST Aquestive Therapeutics, In A Award2025-03-072025-03-11110,000— $0358,295SEC↗
AQST Aquestive Therapeutics, In F Tax w/h2024-03-092024-03-1211,705$4.88 $57.1K248,295SEC↗
AQST Aquestive Therapeutics, In A Award deriv2024-03-072024-03-1160,000— $060,000SEC↗
AQST Aquestive Therapeutics, In A Award2024-03-072024-03-11120,000— $0260,000SEC↗
AQST Aquestive Therapeutics, In A Award deriv2023-08-092023-08-0970,000— $070,000SEC↗
AQST Aquestive Therapeutics, In A Award deriv2023-05-052023-05-0570,000— $070,000SEC↗
AQST Aquestive Therapeutics, In A Award2023-03-092023-03-09140,000— $0140,000SEC↗
AQST Aquestive Therapeutics, In A Award deriv2022-11-042022-11-0840,000— $040,000SEC↗
AQST Aquestive Therapeutics, In A Award deriv2022-03-102022-03-1470,000— $070,000SEC↗
AQST Aquestive Therapeutics, In A Award deriv2021-06-152021-06-17120,000— $0120,000SEC↗
AQST Aquestive Therapeutics, In A Award deriv2021-03-112021-03-152,500— $02,500SEC↗